Literature DB >> 15322056

Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis.

Claudia Manca1, Michael B Reed, Sherry Freeman, Barun Mathema, Barry Kreiswirth, Clifton E Barry, Gilla Kaplan.   

Abstract

In vitro infection of monocytes with Mycobacterium tuberculosis HN878 and related W/Beijing isolates preferentially induced interleukin-4 (IL-4) and IL-13, which characterize Th2 polarized immunity. In contrast, CDC1551 induced more IL-12 and other molecules associated with phagocyte activation and Th1 protective immunity. The differential cytokine-chemokine response was mediated by extracted lipids, suggesting that these molecules regulate host responses to infection.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15322056      PMCID： PMC517425          DOI： 10.1128/IAI.72.9.5511-5514.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains.

Authors:  Pablo J Bifani; Barun Mathema; Natalia E Kurepina; Barry N Kreiswirth
Journal:  Trends Microbiol       Date:  2002-01       Impact factor: 17.079

Review 2.  Alternative versus classical macrophage activation during experimental African trypanosomosis.

Authors:  P D Baetselier; B Namangala; W Noël; L Brys; E Pays; A Beschin
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

Review 3.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

4.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

5.  Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.

Authors:  Olga S Toungoussova; Andrey Mariandyshev; Gunnar Bjune; Per Sandven; Dominique A Caugant
Journal:  Clin Infect Dis       Date:  2003-08-14       Impact factor: 9.079

6.  Human macrophage activation programs induced by bacterial pathogens.

Authors:  Gerard J Nau; Joan F L Richmond; Ann Schlesinger; Ezra G Jennings; Eric S Lander; Richard A Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

7.  Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology.

Authors:  P J Bifani; B Mathema; Z Liu; S L Moghazeh; B Shopsin; B Tempalski; J Driscol; R Frothingham; J M Musser; P Alcabes; B N Kreiswirth
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

8.  Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients.

Authors:  A van Rie; R M Warren; N Beyers; R P Gie; C N Classen; M Richardson; S L Sampson; T C Victor; P D van Helden
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

9.  Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages.

Authors:  L D Sibley; S W Hunter; P J Brennan; J L Krahenbuhl
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam.

Authors:  Nguyen Thi Ngoc Lan; Hoang Thi Kim Lien; Le B Tung; Martien W Borgdorff; Kristin Kremer; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883
View more
  98 in total

1.  Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis.

Authors:  Rogelio Hernandez Pando; Leon Diana Aguilar; Issar Smith; Riccardo Manganelli
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

Review 2.  Comparative genomics of mycobacteria: some answers, yet more new questions.

Authors:  Marcel A Behr
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-13       Impact factor: 6.915

3.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

4.  Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RD(Rio) Mycobacterium tuberculosis sublineage.

Authors:  Scott A Weisenberg; Andrea L Gibson; Richard C Huard; Natalia Kurepina; Heejung Bang; Luiz C O Lazzarini; Yalin Chiu; Jiehui Li; Shama Ahuja; Jeff Driscoll; Barry N Kreiswirth; John L Ho
Journal:  Infect Genet Evol       Date:  2011-08-02       Impact factor: 3.342

5.  Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

Authors:  Leander Grode; Peter Seiler; Sven Baumann; Jürgen Hess; Volker Brinkmann; Ali Nasser Eddine; Peggy Mann; Christian Goosmann; Silke Bandermann; Debbie Smith; Gregory J Bancroft; Jean-Marc Reyrat; Dick van Soolingen; Bärbel Raupach; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

6.  Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis.

Authors:  Maxine Caws; Guy Thwaites; Kasia Stepniewska; Thi Ngoc Lan Nguyen; Thi Hong Duyen Nguyen; Thi Phuong Nguyen; Nguyet Thu Huyen Mai; Minh Duy Phan; Huu Loc Tran; Thi Hong Chau Tran; Dick van Soolingen; Kristin Kremer; Van Vinh Chau Nguyen; Tran Chinh Nguyen; Jeremy Farrar
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

7.  Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity.

Authors:  Ernestas Janulionis; Carolina Sofer; Stephan K Schwander; Denarra Nevels; Barry Kreiswirth; Elena Shashkina; Robert S Wallis
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 9.  The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.

Authors:  S Basu; A P Galvani
Journal:  Epidemiol Infect       Date:  2008-07-07       Impact factor: 2.451

10.  Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.

Authors:  Susan L Baldwin; Valerie A Reese; Po-Wei D Huang; Elyse A Beebe; Brendan K Podell; Steven G Reed; Rhea N Coler
Journal:  Clin Vaccine Immunol       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.